Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Castration-Resistant Prostate Adenocarcinoma”

113 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 113 results

Early research (Phase 1)Study completedNCT03811652
What this trial is testing

A Multiple Ascending Dose Study of MEDI7247 in Advanced or Metastatic Solid Tumors

Who this might be right for
Non Small Cell Lung Cancer Squamous (NSCLC-Sq)Head and Neck Squamous Cell Carcinoma (HNSCC)Small Cell Lung Cancer (SCLC)+3 more
MedImmune LLC 8
Early research (Phase 1)Looking for participantsNCT07219147
What this trial is testing

177^Lu-PSMA-617 in Combination With Sipuleucel-T for the Treatment of Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Metastatic Castration-Resistant Prostate AdenocarcinomaStage IVB Prostate Cancer AJCC v8
City of Hope Medical Center 30
Early research (Phase 1)Temporarily pausedNCT01337518
What this trial is testing

A Phase 1a/1b Study to Evaluate the Safety of EZN-4176, in Adult Patients With Castration-Resistant Prostate Cancer

Who this might be right for
Prostatic Neoplasm
Enzon Pharmaceuticals, Inc. 150
Testing effectiveness (Phase 2)Looking for participantsNCT04704505
What this trial is testing

Bipolar Androgen Therapy (BAT) and Radium-223 (RAD) in Metastatic Castration-resistant Prostate Cancer (mCRPC)

Who this might be right for
Prostate AdenocarcinomaMetastatic Prostate AdenocarcinomaCastration-resistant
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 47
Testing effectiveness (Phase 2)Study completedNCT04019327
What this trial is testing

The Drugs Talazoparib and Temozolomide in Prostate Cancer

Who this might be right for
Prostate CancerProstate AdenocarcinomaProstate Neoplasm+2 more
Memorial Sloan Kettering Cancer Center 16
Testing effectiveness (Phase 2)Ended earlyNCT02215161
What this trial is testing

Selinexor in Treating Patients With Abiraterone Acetate and/or Enzalutamide Refractory Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Castration Levels of TestosteroneHormone-Resistant Prostate CancerMetastatic Prostate Carcinoma in the Soft Tissue+3 more
University of California, San Francisco 14
Early research (Phase 1)Active Not RecruitingNCT03845166
What this trial is testing

XL092 as Single-Agent and Combination Therapy in Subjects With Solid Tumors

Who this might be right for
Neoplasm MalignantRenal Cell CarcinomaHormone Receptor Positive Breast Carcinoma+2 more
Exelixis 325
Testing effectiveness (Phase 2)Active Not RecruitingNCT03360721
What this trial is testing

Apalutamide, Abiraterone Acetate, and Prednisone in Treating Participants With Metastatic Castration Resistant Prostate Cancer

Who this might be right for
Castration-Resistant Prostate CarcinomaProstate Adenocarcinoma Without Neuroendocrine DifferentiationStage IV Prostate Cancer AJCC v8+2 more
M.D. Anderson Cancer Center 7
Testing effectiveness (Phase 2)Looking for participantsNCT03972657
What this trial is testing

A Trial to Find Out if REGN5678 (Nezastomig) is Safe and How Well it Works Alone or in Combination With Cemiplimab for Adult Participants With Metastatic Castration-Resistant Prostate Cancer and Other Tumors

Who this might be right for
Metastatic Castration-Resistant Prostate Cancer (mCRPC)Clear Cell Renal Cell Carcinoma (ccRCC)
Regeneron Pharmaceuticals 345
Testing effectiveness (Phase 2)Active Not RecruitingNCT03317392
What this trial is testing

Testing the Safety of Different Doses of Olaparib Given Radium-223 for Men With Advanced Prostate Cancer With Bone Metastasis

Who this might be right for
Castration-Resistant Prostate CarcinomaMetastatic Prostate AdenocarcinomaStage IVB Prostate Cancer AJCC v8
National Cancer Institute (NCI) 133
Not applicableStudy completedNCT02236637
What this trial is testing

A Registry to Observe the Treatment of Prostate Cancer Under Routine Medical Care

Who this might be right for
Prostate Cancer
Janssen Pharmaceutica N.V., Belgium 3,050
Testing effectiveness (Phase 2)Study completedNCT03406858
What this trial is testing

Pembro and HER2Bi-Armed Activated T Cells in Treating Patients With Metastatic Castration Resistant Prostate Cancer

Who this might be right for
Castration Levels of TestosteroneCastration-Resistant Prostate CarcinomaProstate Carcinoma Metastatic in the Bone+2 more
Barbara Ann Karmanos Cancer Institute 15
Early research (Phase 1)WithdrawnNCT01685489
What this trial is testing

A Phase 1b Dose Escalation Trial of PSK®/Placebo With Docetaxel to Treat Metastatic Castration-resistant Prostate Cancer

Who this might be right for
Prostatic Neoplasms
Bastyr University
Testing effectiveness (Phase 2)UnknownNCT06221774
What this trial is testing

Safety and Efficacy of TT-00420 Tablets Combined With Toripalimab Injection in Advanced Urological Tumors

Who this might be right for
Clear Cell Renal CarcinomaUrothelial CarcinomaMetastatic Castration-resistant Prostate Cancer
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 42
Testing effectiveness (Phase 2)Study completedNCT01270880
What this trial is testing

Hsp90 Inhibitor STA-9090 in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer Previously Treated With Docetaxel-Based Chemotherapy

Who this might be right for
Adenocarcinoma of the ProstateHormone-resistant Prostate CancerRecurrent Prostate Cancer+1 more
Barbara Ann Karmanos Cancer Institute 18
Testing effectiveness (Phase 2)WithdrawnNCT02793765
What this trial is testing

Docetaxel Followed by Provenge in Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
The University of Texas Health Science Center, Houston
Testing effectiveness (Phase 2)Ended earlyNCT03207867
What this trial is testing

NIR178 in Combination With PDR001 in Patients With Solid Tumors and Non-Hodgkin Lymphoma

Who this might be right for
NSCLC, Non Small Cell Lung CancerRCC, Renal Cell CancerPancreatic Cancer+7 more
Novartis Pharmaceuticals 315
Testing effectiveness (Phase 2)Looking for participantsNCT06145633
What this trial is testing

Vorinostat and 177Lu-PSMA-617 for the Treatment of PSMA-Low Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Castration-Resistant Prostate CarcinomaMetastatic Prostate AdenocarcinomaStage IVB Prostate Cancer AJCC v8
Fred Hutchinson Cancer Center 15
Testing effectiveness (Phase 2)Ended earlyNCT04556617
What this trial is testing

PLX2853 in Combination With Abiraterone Acetate and Prednisone and in Combination With Olaparib in Subjects With Metastatic Castration-Resistant Prostate Cancer (mCRPC)

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
Opna Bio LLC 19
Early research (Phase 1)Looking for participantsNCT06966024
What this trial is testing

Study of DCC-2812 in Participants With Advanced Genitourinary Cancers

Who this might be right for
Renal Cell CarcinomaUrothelial CarcinomaCastration-resistant Prostate Cancer
Deciphera Pharmaceuticals, LLC 60
Load More Results